Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand

  1. Home

  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    (0673–0690) Vasculitis – ANCA-Associated Poster I: Treatment Outcomes
    Location: Poster Hall
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    (0691–0721) Vasculitis – Non-ANCA-Associated & Related Disorders Poster I
    Location: Poster Hall
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0673: Reporting of Race, Ethnicity, Sex, Gender, Socioeconomic Status and Representativeness of Race and Ethnicity in ANCA-associated Vasculitis Randomized Trials
    Location: Poster Hall
    Abstract Poster Presenter: Xavier Puéchal, MD, PhD (he/him/his) – National Referral Center for Rare Systemic Autoimmune Diseases
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0674: Efficacy and Safety of Mepolizumab During Maintenance Therapy in Patients with Eosinophilic Granulomatosis with Polyangiitis
    Location: Poster Hall
    Abstract Poster Presenter: Daiki Sakai, -None- – Toho University Graduate school of Medicine
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0675: Investigating the Impact of anti-IL5 Therapy in the Management of Relapsing and Refractory Eosinophilic Granulomatosis with Polyangiitis (EGPA); A Three Year Longitudinal Perspective and Beyond
    Location: Poster Hall
    Abstract Poster Presenter: Allyson Egan, BSc, MRCP – Trinity Health Kidney Centre, Tallaght University Hospital, Ireland
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0676: Mepolizumab Can Achieve Glucocorticoid Discontinuation in Eosinophilic Granulomatosis with Polyangiitis Patients Regardless of IgE Levels: A Retrospective Study at a Single Center
    Location: Poster Hall
    Abstract Poster Presenter: Takashi Yamane, MD, PhD – Kakogawa Central City Hospital
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0677: Analysis of Clinical Outcomes in Eosinophilic Granulomatosis with Polyangiitis (EGPA) Treated with Mepolizumab over 2 Years for Remission Induction or Maintenance: A Single Center Experience in Japan
    Location: Poster Hall
    Abstract Poster Presenter: SOKO KAWASHIMA, MD, PhD – Kyorin University
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0678: Benralizumab in Eosinophilic Granulomatosis with Polyangiitis
    Location: Poster Hall
    Abstract Poster Presenter: Adrien Cottu, MD, -None- – Sorbonne Université
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0679: Long-term Safety of Rituximab (Mabthera) in Granulomatosis with Polyangiitis (GPA) or Microscopic Polyangiitis (MPA): Rituximab Surveillance Study in VASculitis (RIVAS)
    Location: Poster Hall
    Abstract Poster Presenter: Lisa Uchida, MD, PhD – University of Cambridge
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0680: Risk Factors for Hypogammaglobulinemia and Association with Relapse and Severe Infections in ANCA-Associated Vasculitis: A Retrospective Single-Centre Cohort Study
    Location: Poster Hall
    Abstract Poster Presenter: Benjamin Terrier, MD, PhD – Cochin Hospital
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0681: Real-World Outcomes for Remission Induction in Working-Age Adults with Severe Anti-Neutrophil Cytoplasmic Antibody-associated Vasculitis
    Location: Poster Hall
    Abstract Poster Presenter: Itay Marmor, MD – Dana-Dwek Children’s Hospital
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0682: Avacopan in ANCA-associated Vasculitis Received Intensified Induction Therapy with Cyclophosphamide Plus Rituximab – Retrospective Case Serial of 12 Patients
    Location: Poster Hall
    Abstract Poster Presenter: Gunter Assmann, PhD (he/him/his) – RUB University Hospital Minden JWK
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0683: Remission, Glucocorticoid Toxicity, Health-Related Quality of Life, and Safety Outcomes in Patients with Renal Involvement in the Phase 3 Trial of Avacopan for the Treatment of ANCA-Associated Vasculitis
    Location: Poster Hall
    Abstract Poster Presenter: Peter A. Merkel, MD, MPH – University of Pennsylvania
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0684: Report on Twelve Patients with Diffuse Alveolar Hemorrhage in the Phase 3 Trial of Avacopan for the Treatment of ANCA-Associated Vasculitis
    Location: Poster Hall
    Abstract Poster Presenter: Peter A. Merkel, MD, MPH – University of Pennsylvania
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0685: Efficacy and Safety of Avacopan in Patients with ANCA-Associated Vasculitis Receiving Rituximab in a Phase 3 Trial
    Location: Poster Hall
    Abstract Poster Presenter: Anisha Dua, MD, MPH – Northwestern University
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0686: Safety and Efficacy of Avacopan in Patients 65 Years and Older with ANCA-Associated Vasculitis
    Location: Poster Hall
    Abstract Poster Presenter: David R W Jayne, MD – University of Cambridge
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0687: Avacopan for the Treatment of ANCA-associated Vasculitis. Real World Experience in Spain
    Location: Poster Hall
    Abstract Poster Presenter: Maria Cid, MD – Hospital Clinic Barcelona. University of Barcelona
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0688: Efficacy and Safety Experience with Avacopan Beyond 52 Weeks in the Early Access Program (EAP)
    Location: Poster Hall
    Abstract Poster Presenter: Carlo Salvarani, MD – Azienda USL-IRCCS di Reggio Emilia and UNIMORE
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0689: Use of Avacopan in Patients with ANCA-associated Vasculitis and Estimated Glomerular Filtration Rate < 15 mL/min/1.73m2
    Location: Poster Hall
    Abstract Poster Presenter: Stephanie Garner, MD, FRCPC, MSc – University of Calgary
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0690: Treating Patients with ANCA-Associated Vasculitis and Very Severe Renal Injury with an Intensified B Cell Depletion Therapy: Comparison with a Control Cohort Receiving a Conventional Therapy
    Location: Poster Hall
    Abstract Poster Presenter: Dario Roccatello, MD – University of Torino
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0691: Recognizing the New Disorder "Idiopathic Hypocryoglobulinaemia" in Patients with Previously Unidentified Clinical Conditions
    Location: Poster Hall
    Abstract Poster Presenter: Dario Roccatello, MD – University of Torino
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0692: Behçet’s Disease-Associated TCR in the Eye Points to HLA Class I-Restricted Autoimmunity
    Location: Poster Hall
    Abstract Poster Presenter: Johannes Nowatzky, MD – NYU Grossman School of Medicine, Department of Medicine, Department of Pathology, Division of Rheumatology, NYU Behçet's Disease Program, NYU Ocular Rheumatology Program
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0693: Comparison of the Cardiovascular Risk in Patients with Vasculitis and Diabetes Mellitus
    Location: Poster Hall
    Abstract Poster Presenter: Ana B Arevalo, MD – Massachusetts General Hospital
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0694: Off-label Use of Biologics in Urticarial Vasculitis: A European Cohort Study
    Location: Poster Hall
    Abstract Poster Presenter: Lucas Maisonobe, MD (he/him/his) – Assistance Publique - Hôpitaux de Paris
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0695: Impact and Cardiovascular Outcomes of Large Vessel Vasculitis in Atrial Fibrillation Hospitalization: A Nationwide Inpatient Database Study
    Location: Poster Hall
    Abstract Poster Presenter: Sabahat Usmani, MD (she/her/hers) – WEISS Memorial Hospital
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0696: Association of Large-vessel Vasculitis with Inflammatory Bowel Diseases: A European Case-control Study
    Location: Poster Hall
    Abstract Poster Presenter: François Maillet, MD, MSc (he/him/his) – University of Paris
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0697: Alterations in Composition and Function of Gut Microbiota in Patients with Large-Vessel Vasculitis
    Location: Poster Hall
    Abstract Poster Presenter: Adam Mayer, MD – University of Pennsylvania/Children's Hospital of Philadelphia
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0698: Differentiating Large Vessel Vasculitis from Vasculitis Mimickers in a Real World Setting: Clinical Presentation, Laboratory Tests and Radiographic Findings
    Location: Poster Hall
    Abstract Poster Presenter: James Haigney, MD – Beth Israel Deaconess Medical Center
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0699: T Cell Subset Analysis in Patients with Large-Vessel Vasculitis
    Location: Poster Hall
    Abstract Poster Presenter: Rebecca Kuan, BA (she/her/hers) – Western University of Health Sciences
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0700: A Population-Based Study of Vasculitis Among Farmers and Urban Residents in Alberta
    Location: Poster Hall
    Abstract Poster Presenter: Elaine Yacyshyn, MD (she/her/hers) – University of Alberta
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0701: Incidence of Neurobehçet Disease in Northern Spain 1999-2019. a Population-based Study
    Location: Poster Hall
    Abstract Poster Presenter: Fabricio Benavides, MD (he/him/his) РHospital Universitario Marqu̩s de Valdecilla
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0702: Large Vessel Vasculitis Increases Risk of Acute Myocardial Infarction in Patients Admitted for Congestive Heart Failure : A Nationwide Inpatient Database Study
    Location: Poster Hall
    Abstract Poster Presenter: Yanint Raksadawan, MD (she/her/hers) – Weiss Memorial Hospital
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0703: Cardiovascular Disease-Related Mortality in Primary Systemic Vasculitis
    Location: Poster Hall
    Abstract Poster Presenter: Alicia Rodriguez-Pla, MD, PhD, RhMSUS, MPH, FACP – Sierra Pacific Arthritis and Rheumatology Centers
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0704: Clinical Characteristics and Outcomes in Patients Found to Have Clinically Isolated Aortitis After Aortic Aneurysm Repair: A Single-Center Experience
    Location: Poster Hall
    Abstract Poster Presenter: Julia Ford, MD – University of Michigan
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0705: Sleep Disturbances in Patients with Vasculitis: Results of the Vasculitis Patient-Powered Research Network Sleep Study (SleepVasc)
    Location: Poster Hall
    Abstract Poster Presenter: Lillian Barra, MD, MPH, H.BSc – Western University
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0706: Aortitis and Periaortitis Spectrum in 135 Patients from a Single Referral Centre
    Location: Poster Hall
    Abstract Poster Presenter: Fernando López-Gutierrez, PhD – Rheumatology, Hospital Universitario Marqués de Valdecilla
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0707: Prevalence and Distribution of Vascular Calcifications at CT Scan in Patients with Large Vessel Vasculitis and Patients with Lymphoma: A Matched Cross-sectional Study
    Location: Poster Hall
    Abstract Poster Presenter: Chiara Marvisi, MD – University of Modena e Reggio Emilia
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0708: NFKB1 and NFKBIA: Relevant Players in the Pathogenesis of IgA Vasculitis?
    Location: Poster Hall
    Abstract Poster Presenter: Veronica Pulito Cueto, PhD – IDIVAL
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0709: Survival of Adults with IgA Vasculitis
    Location: Poster Hall
    Abstract Poster Presenter: Alojzija Hocevar, MD, PhD – University Medical Center Ljubljana
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0710: The Association of IgA Vasculitis and Malignancy in Adults: A Systematic Review
    Location: Poster Hall
    Abstract Poster Presenter: Hila Ghersin, BA – Albert Einstein College of Medicine
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0711: IgA Vasculitis in a Diverse Adult Patient Population
    Location: Poster Hall
    Abstract Poster Presenter: Bibi Ayesha, MD – Montefiore Medical Center
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0712: Clinical and Histologic Prognostic Factors of Renal Progression in Adults with IgA Vasculitis
    Location: Poster Hall
    Abstract Poster Presenter: Meenakshi Vanka, MD – Oregon Health & Science University/Emory
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0713: IgG4-Related Disease as a Potencial Etiology of Idiopathic Constrictive Pericarditis
    Location: Poster Hall
    Abstract Poster Presenter: Eduardo Martin-Nares, MD, MSc – Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0714: Single Center Experience of Rituximab Treatment for IgG4-RD Disease in a Large Multi-ethnic Cohort
    Location: Poster Hall
    Abstract Poster Presenter: Matthew Colquhoun, MBBS, MRCP – Hammersmith Hospital
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0715: Glucocorticoid Toxicity in Patients with IgG4-Related Disease Within the First Year of Treatment
    Location: Poster Hall
    Abstract Poster Presenter: Eduardo Martin-Nares, MD, MSc – Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0716: Efficacy of Immunosuppressants for Disease Relapse in Patients with IgG4-related Disease at Our Institution
    Location: Poster Hall
    Abstract Poster Presenter: Kanako Chujo, MD – Kagawa university
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0717: Mitochondria-mediated Platelet Activation in Polymyalgia Rheumatica
    Location: Poster Hall
    Abstract Poster Presenter: Despina Michailidou, MD (she/her/hers) – University of Oklahoma and VA Medical Center
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0718: Clinical and Economic Burden of Polymyalgia Rheumatica in Patients with an Inadequate Response to Glucocorticoids in a Real-World Setting
    Location: Poster Hall
    Abstract Poster Presenter: Jeffrey Curtis, MD, MS, MPH – University of Alabama at Birmingham
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0719: Polymyalgia Rheumatica Following SarsCOV-2 Vaccination: A Single Center Cohort Study
    Location: Poster Hall
    Abstract Poster Presenter: Lindsay Lally, MD – Hospital for Special Surgery
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0720: Cognitive Function and Its Associated Factors in Polymyalgia Rheumatica
    Location: Poster Hall
    Abstract Poster Presenter: Patricia Harkins, MD – Trinity College Dublin
    Vasculitis
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0721: Characterization of Numeric Rating Scales for Symptom Assessment in Polymyalgia Rheumatica
    Location: Poster Hall
    Abstract Poster Presenter: David Katz, PhD – Sparrow Pharmaceuticals
    Vasculitis
  • Sunday, Nov 12th
    12:00 PM – 12:10 PM PT
    0725: Real-life Use of the PEXIVAS Reduced-dose Glucocorticoid Regimen in Granulomatosis with Polyangiitis and Microscopic Polyangiitis
    Location: Exhibit Hall A-B
    Plenary Presenter: Sophie Nagle (she/her/hers) – Université Paris Saclay
    Vasculitis
  • Sunday, Nov 12th
    2:00 PM – 3:00 PM PT
    12S136: CARE: Central Nervous System Vasculitis
    Location: Exhibit Hall A-B
    Moderator: Lillian Barra, MD, MPH, H.BSc – Western University
    Vasculitis
     CME: 1 hours
  • Sunday, Nov 12th
    2:00 PM – 2:45 PM PT
    CARE: Central Nervous System Vasculitis
    Location: Exhibit Hall A-B
    Speaker: Rula A. A. Hajj-Ali, MD – Cleveland Clinic
    Vasculitis
  • Sunday, Nov 12th
    2:45 PM – 3:00 PM PT
    Q&A
    Location: Exhibit Hall A-B
    Vasculitis
  • Sunday, Nov 12th
    4:00 PM – 5:30 PM PT
    12S170: Abstracts: Vasculitis – ANCA-Associated I (0853–0858)
    Location: Ballroom 20D
    Abstract Moderator: Gunnar Tomasson, MD – University of Iceland
    Abstract Moderator: Jessica Bloom, MD, MS – University of Colorado
    Vasculitis
  • Sunday, Nov 12th
    4:00 PM – 4:10 PM PT
    0853: Early Experience with Avacopan for ANCA-Associated Vasculitis in a Large Integrated Healthcare System
    Location: Ballroom 20D
    Presenting Author: Zachary Wallace, MD, MSc – Massachusetts General Hospital
    Vasculitis
  • Sunday, Nov 12th
    4:15 PM – 4:25 PM PT
    0854: Long-term Efficacy of Remission-induction Regimens for Eosinophilic Granulomatosis with Polyangiitis
    Location: Ballroom 20D
    Presenting Author: Martin Dutertre, MD (he/him/his) – AP-HP
    Vasculitis
  • Sunday, Nov 12th
    4:30 PM – 4:40 PM PT
    0855: Real-world Experience with Avacopan in ANCA Vasculitis: A Multi-center Retrospective Cohort Analysis
    Location: Ballroom 20D
    Presenting Author: Sebastian Sattui, MD, MS (he/him/his) – University of Pittsburgh
    Vasculitis
  • Sunday, Nov 12th
    4:45 PM – 4:55 PM PT
    0856: Dupilumab for Relapsing or Refractory Eosinophilic Granulomatosis with Polyangiitis: A European Retrospective Study
    Location: Ballroom 20D
    Presenting Author: Berengere Molina, MD – Cochin Hospital
    Vasculitis
  • Sunday, Nov 12th
    5:00 PM – 5:10 PM PT
    0857: Change in Albuminuria in Patients with ANCA-Associated Vasculitis Treated with Avacopan
    Location: Ballroom 20D
    Presenting Author: David R W Jayne, MD – University of Cambridge
    Vasculitis
  • Sunday, Nov 12th
    5:15 PM – 5:25 PM PT
    0858: Randomized, Controlled, Double-Blind Trial on the Impact of Rosuvastatin on Sublinical Markers of Atherosclerosis in Patients with ANCA-Associated Vasculitis
    Location: Ballroom 20D
    Presenting Author: Benjamin Terrier, MD, PhD – Cochin Hospital
    Vasculitis
  • Monday, Nov 13th
    7:30 AM – 9:00 AM PT
    13M107: ACR-EULAR Criteria for Clinical Response in ANCA-Associated Vasculitis: A Composite Outcome Measure
    Location: Ballroom 20A
    Moderator: Jason Springer, MD, MS – Vanderbilt University Medical Center
    Vasculitis
     CME: 1.5 hours
  • Monday, Nov 13th
    7:30 AM – 7:40 AM PT
    Introduction to the Project and Rationale for Developing Criteria for Response for ANCA-Associated Vasculitis
    Location: Ballroom 20A
    Speaker: Peter A. Merkel, MD, MPH – University of Pennsylvania
    Vasculitis
  • Monday, Nov 13th
    7:40 AM – 7:50 AM PT
    Results of the Systematic Literature Review and Delphi Exercise
    Location: Ballroom 20A
    Virtual Speaker: Kaitlin Quinn, MD, MHS – National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
    Vasculitis
  • Monday, Nov 13th
    7:50 AM – 8:00 AM PT
    Draft Response Criteria
    Location: Ballroom 20A
    Speaker: Sara Monti, MD, PhD – University of Pavia
    Vasculitis
  • Monday, Nov 13th
    8:00 AM – 8:10 AM PT
    Candidate Items for the Response Criteria and Methods for Arriving at Weights
    Location: Ballroom 20A
    Speaker: Gunnar Tomasson, MD – University of Iceland
    Vasculitis
  • Monday, Nov 13th
    8:10 AM – 8:20 AM PT
    Validation of Response Criteria and Next Steps/Implementation
    Location: Ballroom 20A
    Speaker: Peter A. Merkel, MD, MPH – University of Pennsylvania
    Vasculitis
  • Monday, Nov 13th
    8:10 AM – 9:00 AM PT
    Q&A
    Location: Ballroom 20A
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    (1534–1553) Vasculitis – ANCA-Associated Poster II: Epidemiology, Outcomes, & Classification
    Location: Poster Hall
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    (1554–1578) Vasculitis – Non-ANCA-Associated & Related Disorders Poster II
    Location: Poster Hall
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1534: ANCA-associated Vasculitis Incidence in a Norther Spanish Health Region
    Location: Poster Hall
    Abstract Poster Presenter: Salma Al Fazazi (she/her/hers) – Hospital Universitario Puerta Del Mar
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1535: Epidemiology and Treatment Outcome of ANCA-associated Vasculitis in South Korea: A Nationwide, Population-based Cohort Study
    Location: Poster Hall
    Abstract Poster Presenter: Ji In Jung, MD – Seoul National University Hospital
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1536: The Impact of COVID-19 Vaccination on ANCA Vasculitis Hospitalisations: A Perspective from Sydney Australia
    Location: Poster Hall
    Abstract Poster Presenter: Anthony Sammel, PhD, MBBS – Prince of Wales Hospital
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1537: Long-term Observational Study of Interstitial Lung Disease in ANCA-associated Vasculitis
    Location: Poster Hall
    Abstract Poster Presenter: David R W Jayne, MD – University of Cambridge
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1538: Large Vessel Involvement in Antineutrophil Cytoplasmic Antibody- Associated Vasculitis: A Single Center Experience over Two Decades
    Location: Poster Hall
    Abstract Poster Presenter: Mahmut Kaymakci, MD – Mayo Clinic
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1539: Digital Ischemia, a Rare Manifestation in Anti-neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis (AAV)
    Location: Poster Hall
    Abstract Poster Presenter: Kinanah Yaseen, MD – Cleveland Clinic
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1540: Evaluation of the Validity of the 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Antineutrophil Cytoplasmic Antibody-associated Vasculitis for an Asian Population on the Basis of the Patterns of Organ Involvement
    Location: Poster Hall
    Abstract Poster Presenter: Ryo Kuwata, MD – Division of Rheumatic diseases, National Center for Global Health and Medicine
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1541: Neurologic Involvement Does Not Affect Cumulative Survival Rates in Patients with ANCA-associated Vasculitis and Is Less Commonly Associated with Rapidly Progressive Glomerulonephritis in Patients with GPA
    Location: Poster Hall
    Abstract Poster Presenter: Gatr-alnada Gheriani, MD, MBChB – University of Iowa Hospital and Clinics
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1542: The Burden of Multimorbidity in ANCA-Associated Vasculitis: A Cohort Study
    Location: Poster Hall
    Abstract Poster Presenter: Zachary Wallace, MD, MSc – Massachusetts General Hospital
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1543: The Association of Frailty with Outcomes in Patients with Vasculitis
    Location: Poster Hall
    Abstract Poster Presenter: Sebastian Sattui, MD, MS (he/him/his) – University of Pittsburgh
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1544: Increased Risk of Severe Infection in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitides: A Population-based Trend Analysis
    Location: Poster Hall
    Abstract Poster Presenter: Kai Zhao, MSc – Simon Fraser University
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1545: Validation of the 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria in Patients with ANCA-associated Vasculitis
    Location: Poster Hall
    Abstract Poster Presenter: Liubov Petelytska, MD, PhD – Bogomolets National Medical University
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1546: Eosinophilic Granulomatosis with Polyangiitis: Clinical Suspicion Red Flags Identification by a Systematic Literature Review and Multidisciplinary Expert Consensus
    Location: Poster Hall
    Abstract Poster Presenter: Ricardo Blanco, PhD – Hospital Universitario Marqués de Valdecilla, IDIVAL
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1547: Disease Burden of Eosinophilic Granulomatosis with Polyangiitis (EGPA): A Retrospective Analysis of US Health Insurance Claims Data
    Location: Poster Hall
    Abstract Poster Presenter: Karina Keogh, MD – Mayo Clinic
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1548: Diagnosis Pathways in Patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA): A Retrospective Analysis of US Health Insurance Claims Data
    Location: Poster Hall
    Abstract Poster Presenter: Karina Keogh, MD – Mayo Clinic
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1549: Treatment Patterns for Eosinophilic Granulomatosis with Polyangiitis (EGPA): A Retrospective Analysis of US Health Insurance Claims Data
    Location: Poster Hall
    Abstract Poster Presenter: Stephanie Chen, PhD – AstraZeneca Pharmaceuticals LP
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1550: Importance of Shared Decision-Making for Patients with ANCA-Associated Vasculitis
    Location: Poster Hall
    Abstract Poster Presenter: Sara Monti, MD, PhD – University of Pavia
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1551: Measurement of Sinonasal Disease Activity in Granulomatosis with Polyangiitis
    Location: Poster Hall
    Abstract Poster Presenter: Rennie Rhee, MD, MS – University of Pennsylvania
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1552: Epidemiology and Outcome of Eosinophilic Granulomatosis with Polyangiitis in France
    Location: Poster Hall
    Abstract Poster Presenter: Benjamin Terrier, MD, PhD – Cochin Hospital
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1553: Central Nervous System Involvement and Mimickers in ANCA Associated Vasculitis
    Location: Poster Hall
    Abstract Poster Presenter: Sinem Esatoglu, MD – Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1554: Therapeutic Approaches and Predictive Factors of Relapse in Severe Ocular Involvement in Behçet's Disease: A Multicentre Retrospective Study
    Location: Poster Hall
    Abstract Poster Presenter: Benjamin Terrier, MD, PhD – Cochin Hospital
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1555: Axial Spondyloarthritis in Patients with Gastrointestinal Involvement of Behçet Syndrome
    Location: Poster Hall
    Abstract Poster Presenter: Sinem Esatoglu, MD – Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1556: Abdominal Surgical Interventions Among Patients with Gastrointestinal Involvement of Behçet Syndrome
    Location: Poster Hall
    Abstract Poster Presenter: Sinem Esatoglu, MD – Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1557: De Novo Manifestations During Adalimumab Treatment in Behçet Syndrome
    Location: Poster Hall
    Abstract Poster Presenter: Sinem Esatoglu, MD – Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1558: Development of Posterior Uveitis in Behçet’s Syndrome Patients with Vitreous Cells Without Any Other Posterior Involvement
    Location: Poster Hall
    Abstract Poster Presenter: Sinem Esatoglu, MD – Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1559: Comparison of Treatment with Adalimumab, Infliximab and Certolizumab in Refractory Cystoid Macular Edema Due to Behçet Disease
    Location: Poster Hall
    Abstract Poster Presenter: Nuria Barroso Garcia, -None- – Hospital Universitario Puerta del Mar
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1560: Decreased Level of Peripheral CLA+ Treg Is a Protective Factor of Nervous System Involvement in Behcet’s Syndrome: A Real-World Study in China
    Location: Poster Hall
    Abstract Poster Presenter: Jiachen Li, MD – Peking University People's Hospital
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1561: Clinical Features and Quality of Life of Japanese Bechet’s Disease Patients with Arthritis: A Japanese Monocentric Study
    Location: Poster Hall
    Abstract Poster Presenter: Koichi Sugihara, MD – Kagawa University
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1562: Behcet’s Disease Coagulopathy in a Racially Diverse Patient Population
    Location: Poster Hall
    Abstract Poster Presenter: Sundus Mian, MD – Mount Sinai
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1563: Methotrexate: A Safe and Effective Therapeutic Alternative in Behçet´s Disease
    Location: Poster Hall
    Abstract Poster Presenter: Miriam Retuerto Guerrero, MD – Complejo Asistencial Universitario de León
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1564: Common Femoral Vein Wall Thickness Measurement as a Diagnostic Test in Suspected Behçet’s Disease
    Location: Poster Hall
    Abstract Poster Presenter: Haner Direskeneli, MD – Marmara University
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1565: Baseline Vascular Ultrasound of Polymyalgia Rheumatica Patients at Time of Diagnosis Predicts Clinical Outcomes at 3 Months
    Location: Poster Hall
    Abstract Poster Presenter: Sharon Cowley, MRCP, MBBCH – Tallaght University Hospital, Dublin
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1566: Exposure-Response Analysis of Sarilumab in Patients with Polymyalgia Rheumatica
    Location: Poster Hall
    Abstract Poster Presenter: Hubert van Hoogstraten, MD, PhD – Sanofi
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1567: Assessment of the Extent and Accrual of Damage in Takayasu’s Arteritis
    Location: Poster Hall
    Abstract Poster Presenter: Tanaz Kermani, MD, MS – University of California Los Angeles
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1568: Comparison of Methotrexate and Azathioprine as the First Steroid-Sparing Immunosuppressive Agent in Patients with Takayasu's Arteritis
    Location: Poster Hall
    Abstract Poster Presenter: Haner Direskeneli, MD – Marmara University
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1569: Efficacy and Safety of Tofacitinib and Tocilizumab in 84 Patients with Takayasu Arteritis: Single-Center Post-Hoc Analysis of a Prospective Study
    Location: Poster Hall
    Abstract Poster Presenter: Jing Li, MD – Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1570: Prognostic Assessment of the 2022 ACR/EULAR Classification Criteria for Takayasu Arteritis: A Multi-centre International Study
    Location: Poster Hall
    Abstract Poster Presenter: Corrado Campochiaro, MD – IRCCS San Raffaele Hospital. Vita-Salute San Raffaele University
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1571: Tocilizumab in Pregnant Takayasu Arteritis - The Use of Tocilizumab at Conception and Throughout Pregnancy in Those with Takayasu Arteritis
    Location: Poster Hall
    Abstract Poster Presenter: Nurul Aulia Zakaria, MBBS, MMed – IMPERIAL COLLEGE LONDON / ASIA PACIFIC RHEUMATOLOGY SOCIETY (APLAR) MEMBER/ MALAYSIAN SOCIETY OF RHEUMATOLOGY (MSR)
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1572: Long-term Efficacy and Retention Rate of Molecular Targeted Drugs in Takayasu Arteritis
    Location: Poster Hall
    Abstract Poster Presenter: Tsuyoshi Shirai, MD, PhD – Tohoku University
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1573: Inpatient Prevalence and Comorbidity of Takayasu’s Arteritis: Nationwide Inpatient Sample 2016-2020
    Location: Poster Hall
    Abstract Poster Presenter: Husam El Sharu, MD – East Carolina University
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1574: The Role of 18F-FDG PET/CT Scans in Takayasu Arteritis
    Location: Poster Hall
    Abstract Poster Presenter: Shirish Sangle, MD, MBBS – Guy's and St Thomas' Hospital NHS FoundationTrust
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1576: Application of the 2022 ACR/EULAR Criteria for Takayasu Arteritis to Previously Diagnosed Patients Based on the 1990 ACR Criteria
    Location: Poster Hall
    Abstract Poster Presenter: Jang Woo Ha, MD – Yonsei university college of medicine
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1577: Analysis of Takayasu’s Arteritis as Risk Factor for Acute Coronary Syndrome
    Location: Poster Hall
    Abstract Poster Presenter: Maria Romero Noboa, MD – John H. Stroger, Jr. Hospital of Cook County
    Vasculitis
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1578: Impact of Anxiety or Depression Status and Fibromyalgia on Adherence to Treatment of Patients with Takayasu Arteritis
    Location: Poster Hall
    Abstract Poster Presenter: Alejandra Espinosa-Orantes, MB – Instituto Nacional de Cardiología Ignacio Chávez
    Vasculitis
  • Monday, Nov 13th
    12:15 PM – 12:25 PM PT
    1584: Effect of Trimethoprim Sulfamethoxazole Prophylaxis on Infections During Treatment of Granulomatosis with Polyangiitis with Rituximab: A Population-Based Study
    Location: Exhibit Hall A-B
    Plenary Presenter: Arielle Mendel, MD, FRCPC, MSc – McGill University Health Centre
    Vasculitis
  • Monday, Nov 13th
    2:00 PM – 3:30 PM PT
    13M152: Abstracts: Vasculitis – Non-ANCA-Associated & Related Disorders I: Imaging (1645–1650)
    Location: Room 6E/6D
    Abstract Moderator: Brendan Antiochos, MD – Johns Hopkins
    Abstract Moderator: Mina Al-Awqati, MD – University of Illinois
    Vasculitis
  • Monday, Nov 13th
    2:00 PM – 2:10 PM PT
    1645: Aortic Dilatation and PET/CT Vascular Activity at Diagnosis and 5 Years in an Inception Giant Cell Arteritis (GCA) Cohort
    Location: Room 6E/6D
    Presenting Author: Anthony Sammel, PhD, MBBS – Prince of Wales Hospital
    Vasculitis
  • Monday, Nov 13th
    2:15 PM – 2:25 PM PT
    1646: The Real-World Experience of Combined Cranial and Large Vessel FDG-PET/CT in the Investigation of Giant Cell Arteritis
    Location: Room 6E/6D
    Presenting Author: Keren Port, MBBS – The Prince of Wales Hospital
    Vasculitis
  • Monday, Nov 13th
    2:30 PM – 2:40 PM PT
    1647: Association Between Vascular FDG Uptake at Diagnosis and Evolution in Aortic Dimensions in Giant Cell Arteritis: A Prospective Study
    Location: Room 6E/6D
    Presenting Author: Daniel Blockmans, MD – University Hospital Gasthuisberg
    Vasculitis
  • Monday, Nov 13th
    2:45 PM – 2:55 PM PT
    1648: EULAR Recommendations for the Use of Imaging in Large Vessel Vasculitis in Clinical Practice: 2023 Update
    Location: Room 6E/6D
    Presenting Author: Wolfgang Schmidt, MD, MACR – Immanuel Krankenhaus Berlin
    Vasculitis
  • Monday, Nov 13th
    3:00 PM – 3:10 PM PT
    1649: Follow-up Ultrasound Examination in Patients with Newly Diagnosed Giant Cell Arteritis
    Location: Room 6E/6D
    Presenting Author: Valentin Sebastian Schäfer, MD – University Hospital Bonn
    Vasculitis
  • Monday, Nov 13th
    3:15 PM – 3:25 PM PT
    1650: Optic Nerve Sheath Measurement as a Disease Activity Biomarker in Giant Cell Arteritis
    Location: Room 6E/6D
    Presenting Author: Carolyn Ross, MD – University of Montreal
    Vasculitis
  • Monday, Nov 13th
    4:00 PM – 5:00 PM PT
    13M159: IgA Vasculitis
    Location: Ballroom 20D
    Moderator: Jessica Bloom, MD, MS – University of Colorado
    Vasculitis
     CME: 1 hours
  • Monday, Nov 13th
    4:00 PM – 4:20 PM PT
    IgA Vasculitis in Adults: Clinical Manifestations, Management Recommendations, and Disease Outcomes
    Location: Ballroom 20D
    Speaker: Matthew Koster, MD, RhMSUS – Mayo Clinic
    Vasculitis
  • Monday, Nov 13th
    4:20 PM – 4:30 PM PT
    Q&A
    Location: Ballroom 20D
    Vasculitis
  • Monday, Nov 13th
    4:30 PM – 4:50 PM PT
    Renal Involvement in Adults with IgA Vasculitis: Comparing IgA Nephropathy and IgA Vasculitis
    Location: Ballroom 20D
    Speaker: David R W Jayne, MD – University of Cambridge
    Vasculitis
  • Monday, Nov 13th
    4:50 PM – 5:00 PM PT
    Q&A
    Location: Ballroom 20D
    Vasculitis
  • Monday, Nov 13th
    4:00 PM – 5:30 PM PT
    13M171: Vasculitis Cookbook
    Location: Room 6A-B
    Moderator: Brendan Antiochos, MD – Johns Hopkins
    Moderator: Guy Katz, MD – Massachusetts General Hospital
    Vasculitis
     CME: 1.5 hours
  • Monday, Nov 13th
    4:00 PM – 4:20 PM PT
    Eosinophilic Granulomatosis with Polyangiitis: Beyond Evidence-Based Medicine
    Location: Room 6A-B
    Speaker: Anisha Dua, MD, MPH – Northwestern University
    Vasculitis
  • Monday, Nov 13th
    4:20 PM – 4:30 PM PT
    Q&A
    Location: Room 6A-B
    Vasculitis
  • Monday, Nov 13th
    4:30 PM – 4:50 PM PT
    Granulomatosis with Polyangiitis: Beyond Evidence-Based Medicine
    Location: Room 6A-B
    Speaker: Alexandra Villa-Forte, MD, MPH, FACP – Cleveland Clinic
    Vasculitis
  • Monday, Nov 13th
    4:50 PM – 5:00 PM PT
    Q&A
    Location: Room 6A-B
    Vasculitis
  • Monday, Nov 13th
    5:00 PM – 5:20 PM PT
    Takayasu's Arteritis: Beyond Evidence-Based Medicine
    Location: Room 6A-B
    Speaker: Tanaz Kermani, MD, MS – University of California Los Angeles
    Vasculitis
  • Monday, Nov 13th
    5:20 PM – 5:30 PM PT
    Q&A
    Location: Room 6A-B
    Vasculitis
  • Tuesday, Nov 14th
    7:30 AM – 8:30 AM PT
    14T106: Fast-Track Clinics for Rapid Diagnosis and Treatment of Giant Cell Arteritis
    Location: Room 31A-C
    Moderator: Audra Horomanski, MD, RhMSUS (she/her/hers) – Stanford University
    Moderator: Minna Kohler, MD, RhMSUS – Massachusetts General Hospital, Harvard Medical School
    Vasculitis
     CME: 1 hours
  • Tuesday, Nov 14th
    7:30 AM – 7:45 AM PT
    Update on the Current Evidence and Guidelines for Diagnosis of Giant Cell Arteritis
    Location: Room 31A-C
    Speaker: Rennie Rhee, MD, MS – University of Pennsylvania
    Vasculitis
  • Tuesday, Nov 14th
    7:45 AM – 8:00 AM PT
    Fast Track Vasculitis Clinic: Optimizing Use of Ultrasound in Diagnosis and Monitoring of GCA
    Location: Room 31A-C
    Speaker: Wolfgang Schmidt, MD, MACR – Immanuel Krankenhaus Berlin
    Vasculitis
  • Tuesday, Nov 14th
    8:00 AM – 8:15 AM PT
    Fast Track Vasculitis Clinic: A Multimodal Approach to Diagnosis of GCA
    Location: Room 31A-C
    Speaker: Mark Matza, MD, RhMSUS, MBA – Massachusetts General Hospital
    Vasculitis
  • Tuesday, Nov 14th
    8:15 AM – 8:30 AM PT
    Q&A
    Location: Room 31A-C
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    (2370–2386) Vasculitis – ANCA-Associated Poster III: Biomarkers & Renal Outcomes
    Location: Poster Hall
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    (2387–2424) Vasculitis – Non-ANCA-Associated & Related Disorders Poster III
    Location: Poster Hall
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    L14: Efficacy and Safety of Benralizumab Compared with Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis in Patients Receiving Standard of Care Therapy: Phase 3 MANDARA Study
    Location: Poster Hall
    Late-Breaking Poster Presenter: Peter A. Merkel, MD, MPH – University of Pennsylvania
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2370: C5 as a Genetic Marker for Discriminating Between IgA Vasculitis and IgA Nephropathy?
    Location: Poster Hall
    Abstract Poster Presenter: Veronica Pulito Cueto, PhD – IDIVAL
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2371: Plasma and Urine Cytokine Profiles in Active ANCA-Associated Vasculitis
    Location: Poster Hall
    Abstract Poster Presenter: Salem Almaani, MD, MS – The Ohio State University Medical Center
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2372: Soluble Triggering Receptor Expressed on Myeloid Cell-1 Reflects the Cross-sectional Activity of Microscopic Polyangiitis and Granulomatosis with Polyangiitis
    Location: Poster Hall
    Abstract Poster Presenter: Jang Woo Ha, MD – Yonsei university college of medicine
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2373: SIRPα Expression in Systemic Vasculitis
    Location: Poster Hall
    Abstract Poster Presenter: Shubhasree Banerjee, MD, MBBS – University of Pennsylvania
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2374: Torque Teno Virus as a Potential Biomarker for Assessment of Immunocompetence in Patients with ANCA-associated Vasculitis
    Location: Poster Hall
    Abstract Poster Presenter: Balazs Odler, MD, PhD (he/him/his) – Medical University of Graz
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2375: Clinical Characteristics of ANCA-associated Vasculitis with High Levels of Serum Interleukin 7
    Location: Poster Hall
    Abstract Poster Presenter: Shoichi Fukui, MD, PhD – Nagasaki University
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2376: Eosinophil Activation as a Biomarker for Discriminating Active and Remission Phase in ANCA-Associated Vasculitis
    Location: Poster Hall
    Abstract Poster Presenter: Teppei Hashimoto, MD, PhD (he/him/his) – Hyogo Medical University
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2377: The Impact of Chronologic versus Biologic Age on the Risk of Severe Infection, End-Stage Renal Disease, and Death in Older Adults with ANCA-Associated Vasculitis
    Location: Poster Hall
    Abstract Poster Presenter: Sebastian Sattui, MD, MS (he/him/his) – University of Pittsburgh
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2378: Longitudinal Trajectories of Renal Function in ANCA-Associated Vasculitis: Findings from the Expanded Mass General Brigham Cohort
    Location: Poster Hall
    Abstract Poster Presenter: Jennifer Hanberg, MD – Brigham and Women's Hospital
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2379: A Real-World Descriptive Study of Renal Outcomes Among Patients with ANCA-Associated Vasculitis Initiating Remission Induction Therapy
    Location: Poster Hall
    Abstract Poster Presenter: Sam Oh, PhD, MPH – Amgen
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2380: Renal Survival Rate of ANCA-associated Vasculitis in Korea: A Nationwide Population-Based Study Using Claims Data
    Location: Poster Hall
    Abstract Poster Presenter: Chan-Bum Choi, MD, PhD, MPH – Hanyang University Hospital for Rheumatic Diseases
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2381: ANCA-associated Vasculitis and Renal Disease in a Multidisciplinary Outpatient Clinic in Northern Spain
    Location: Poster Hall
    Abstract Poster Presenter: Salma Al Fazazi (she/her/hers) – Hospital Universitario Puerta Del Mar
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2382: Relapse of Patients with ANCA-associated Vasculitis Who Are on Dialysis
    Location: Poster Hall
    Abstract Poster Presenter: Hansun Song, MD (he/him/his) – Asan medical center
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2383: Clinical Characteristics, Treatment Patterns, and Clinical Outcomes in Patients with Dual Positive Anti-Neutrophil Cytoplasmic Antibody and Anti-Glomerular Basement Membrane Antibody: A Single Center Experience
    Location: Poster Hall
    Abstract Poster Presenter: Zaina Shahid, MD – Allegheny Health Network
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2384: Major Cardiovascular Adverse Events in Patients with ANCA Vasculitis Compared with Hypertension Control Group
    Location: Poster Hall
    Abstract Poster Presenter: Lisa Rosenberg, DO – Albany Medical College
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2385: Risk of Major Adverse Cardiovascular Events in ANCA-associated Vasculitis
    Location: Poster Hall
    Abstract Poster Presenter: Gregory Pugnet, MD, PhD – CHU Toulouse Rangueil Service de Medecine Interne et Immunologie Clinique
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2386: Impact of ANCA Specificity on Risk of Major Adverse Cardiovascular Events in ANCA-associated Vasculitis
    Location: Poster Hall
    Abstract Poster Presenter: Gregory Pugnet, MD, PhD – CHU Toulouse Rangueil Service de Medecine Interne et Immunologie Clinique
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2387: Large Vessel Involvement and the Risk of Severe Infections in Patients with Giant Cell Arteritis – a Population-based Study
    Location: Poster Hall
    Abstract Poster Presenter: Carl Turesson, MD, PhD – Lund University
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2388: Increased Risk of Severe Infections in Early Giant Cell Arteritis: A Population- based Study
    Location: Poster Hall
    Abstract Poster Presenter: Carl Turesson, MD, PhD – Lund University
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2389: Calprotectin (S100A8/S100A9) and Serumamyloid A Are Not Superior to C Reactive Protein and Erythrocyte Sedimentation Rate in Monitoring Disease Activity in Giant Cell Arteritis – Treated with or Without Tocilizumab
    Location: Poster Hall
    Abstract Poster Presenter: Marc Schmalzing, MD – University Hospital Wuerzburg
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2390: Characterization of Senescent Cells in Temporal Arteries of Patients with Giant Cell Arteritis Reveal an Inflammatory Phenotype and Strong Dependence from IL-6
    Location: Poster Hall
    Abstract Poster Presenter: Andreas Goules – Dept. of Pathophysiology, School of Medicine, University of Athens
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2391: Epidemiology and Predictors of Relapse in Giant Cell Arteritis: Results of the ARTESER Register
    Location: Poster Hall
    Abstract Poster Presenter: Javier Narvaez, MD, PhD – Hospital Universitario de Bellvitge
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2392: Characterization of Arterial Dendritic Cells in Polymyalgia Rheumatica and Giant Cell Arteritis
    Location: Poster Hall
    Abstract Poster Presenter: Maxime SAMSON, MD, PhD (he/him/his) – Dijon University Hospital
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2393: CXCL9/IL-6 and MMP3/CD141 Ratio Allow to Discriminate Between Isolated PMR and GCA/PMR Overlap
    Location: Poster Hall
    Abstract Poster Presenter: Maxime SAMSON, MD, PhD (he/him/his) – Dijon University Hospital
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2394: 18f-FDG-PET/CT for Giant Cell Arteritis Detection of Large Vessel Vasculitis: What Should We Take into Consideration? Analytical Study of the Arteser Registry
    Location: Poster Hall
    Abstract Poster Presenter: Paula Valentina Estrada Alarcón, MD – H Moisès Broggi
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2395: Recommendations for Early Referral of Patients with Suspected Polymyalgia Rheumatica: An Initiative from the International Giant Cell Arteritis and Polymyalgia Rheumatica Study Group
    Location: Poster Hall
    Abstract Poster Presenter: Kresten Keller, MD, PhD – Aarhus University Hospital
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2396: Diagnostic Performance of a Newly-Launched Canadian Fast-Track Ultrasound Clinic Performed by Rheumatologists for Diagnosis of Giant Cell Arteritis
    Location: Poster Hall
    Abstract Poster Presenter: Jean-Charles Mourot, MD (he/him/his) – Université de Montréal
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2397: Impact of Exposure to Environmental Air Pollution on the Onset of Giant Cell Arteritis
    Location: Poster Hall
    Abstract Poster Presenter: Milena Bond, MD – Azienda sanitaria dell'Alto Adige
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2398: FDG Uptake in Limb Arteries at Diagnosis of Giant Cell Arteritis and Risk of Relapse: An Observational Cohort Study
    Location: Poster Hall
    Abstract Poster Presenter: Arthur Mageau, MD, MSc – Université Paris Cité
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2399: Ultrasound Is Comparable to Computed Tomography Angiography in Identifying Aortic Aneurysms in Patients with Giant Cell Arteritis
    Location: Poster Hall
    Abstract Poster Presenter: Anne Bull Haaversen, MD – Martina Hansens Hospital
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2400: Applanation Tonometry of the Temporal Arteries in Participants with Suspected Giant Cell Arteritis: A Proof of Concept
    Location: Poster Hall
    Abstract Poster Presenter: Jean-Paul Makhzoum, MD, FRCPC, FACP – Vasculitis Clinic, Canadian Network for Research on Vasculitides, Hopital du Sacre-Coeur de Montreal
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2401: A Study Defining the Optimal Sonographic Parameters for Intima-Media Thickness in Diagnosing Giant Cell Arteritis
    Location: Poster Hall
    Abstract Poster Presenter: Sharon Cowley, MRCP, MBBCH – Tallaght University Hospital, Dublin
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2402: A Retrospective Analysis of Prevalence of Positive Temporal Artery Biopsies in African American Patients with Giant Cell Arteritis (GCA) in a Large Academic Health Center
    Location: Poster Hall
    Abstract Poster Presenter: Haya Haddad, MD – Medstar Washington Hospital Center
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2403: Systole and Diastole Ultrasound Wall Thickness Shows Significant Differences That Affect the Diagnosis and Assessment of Giant Cell Arteritis
    Location: Poster Hall
    Abstract Poster Presenter: Emma Brugarolas – Rheumatology
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2404: Subclinical Giant Cell Arteritis in Polimialgia Rheumatica: A Biomarker of High Relapse Risk
    Location: Poster Hall
    Abstract Poster Presenter: Eugenio De Miguel, MD, PhD – Hospital Universitario La Paz
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2405: Role of Mitochondria in Activation of Platelets in Giant Cell Arteritis
    Location: Poster Hall
    Abstract Poster Presenter: Despina Michailidou, MD (she/her/hers) – University of Oklahoma and VA Medical Center
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2406: Risk of Large Vessel Complications in Patients with Giant Cell Arteritis, a Population-based Study
    Location: Poster Hall
    Abstract Poster Presenter: Mohanad Elfishawi, MD – University of Minnesota
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2407: Immuno-permissive Antigen-presenting Cells in Giant Cell Arteritis
    Location: Poster Hall
    Abstract Poster Presenter: Shozo Ohtsuki, PhD, MS – Mayo Clinic College of Medicine and Science
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2408: The Use of the Southend GCA Probability Score (GCAPS) in Assessing the Risk of Giant Cell Arteritis in Australian Ophthalmological and General Medical Hospital Cohorts
    Location: Poster Hall
    Abstract Poster Presenter: Anthony Sammel, PhD, MBBS – Prince of Wales Hospital
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2409: Concordance of Relapse Symptoms with Initial Baseline Presentation Features Among Patients with Giant Cell Arteritis
    Location: Poster Hall
    Abstract Poster Presenter: Max Guarda, MD – Mayo Clinic
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2410: Tocilizumab versus Methotrexate in Giant Cell Arteritis: A Retrospective Study to Compare Efficacy and Rapidity of These Steroid-sparing Agents in GCA Patients
    Location: Poster Hall
    Abstract Poster Presenter: Elena Treppo, MD – Physician
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2411: C-X-C Motif Chemokine Receptor 4-targeted Molecular Imaging in Giant Cell Arteritis – a Head-to-head Comparison with FDG PET
    Location: Poster Hall
    Abstract Poster Presenter: Marc Schmalzing, MD – University Hospital Wuerzburg
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2412: Evaluation of the Pretest Probability Score, Ultrasound and Biopsy on GCA Diagnose: Data from Real Clinical Practice
    Location: Poster Hall
    Abstract Poster Presenter: Carmen San José Méndez, MD – Rheumatology department, Complexo Hospitalario Universitario A Coruña (CHUAC). Instituto de Investigación Biomédica A Coruña (INIBIC). Spain
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2413: Janus Kinase Inhibitors in Giant Cell Arteritis in Clinical Practice. Real-World Clinical Practice Study and Literature Review
    Location: Poster Hall
    Abstract Poster Presenter: Fernando López-Gutierrez, PhD – Rheumatology, Hospital Universitario Marqués de Valdecilla
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2414: Relapse in Giant Cell Arteritis Treated with Tocilizumab. Predictive Factors
    Location: Poster Hall
    Abstract Poster Presenter: Fernando López-Gutierrez, PhD – Rheumatology, Hospital Universitario Marqués de Valdecilla
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2415: Giant Cell Arteritis Is Associated with Worse Hospital Outcomes in Aortic Aneurysm/Dissection Hospitalizations: A Nationwide United States Population-Based Study
    Location: Poster Hall
    Abstract Poster Presenter: Artem Minalyan, MD – Loma Linda University Health
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2416: Comparison of Clinical, Laboratory and Imaging Features of Relapses Between Takayasu and LV-GCA Patients. an Italian Monocentric Study
    Location: Poster Hall
    Abstract Poster Presenter: Luigi Boiardi, MD, PhD – Ausl Reggio Emilia
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2417: Influence of Histological Tempol Artery Biopsy Findings on Outcomes of Biopsy-proven Giant Cell Arteritis in Italian Patients : A Long Single Center Follow-up Study
    Location: Poster Hall
    Abstract Poster Presenter: Luigi Boiardi, MD, PhD – Ausl Reggio Emilia
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2418: Effectiveness of Dose Spacing with Tocilizumab in Giant Cell Arteritis Treatment
    Location: Poster Hall
    Abstract Poster Presenter: Sharon Cowley, MRCP, MBBCH – Tallaght University Hospital, Dublin
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2419: Visual Manifestations in Giant Cell Arteritis: Identification of Risk Factors from the ARTESER Registry
    Location: Poster Hall
    Abstract Poster Presenter: Juan Molina-Collada, MD (he/him/his) – Hospital General Universitario Gregorio Marañón
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2420: Sex Differences in Giant Cell Arteritis: Data from the ARTESER Registry
    Location: Poster Hall
    Abstract Poster Presenter: Delia Fernandez-Lozano, MD – Hospital de Mérida, Badajoz
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2421: Optic Nerve Sheath Measurement on Ultrasound: A Novel Diagnostic Test for Giant Cell Arteritis
    Location: Poster Hall
    Abstract Poster Presenter: Hussein Baalbaki, MD – Hopital du Sacre-Coeur de Montreal
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2422: Magnetic Resonance Imaging Reflects Disease Activity in the “Giant Cell Arteritis Treatment with Ultra-short Glucocorticoids and Tocilizumab” Trial (The GUSTO Trial)
    Location: Poster Hall
    Abstract Poster Presenter: Lisa Christ, MD – Inselspital, University Bern, Switzerland
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2423: Concordance Between the 1990 ACR Classification Criteria and the New 2022 ACR/EULAR 2022 Criteria in Giant Cell Arteritis
    Location: Poster Hall
    Abstract Poster Presenter: Julio Sanchez Martin, MD – Hospital Universitario Marqués de Valdecilla
    Vasculitis
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2424: Exploring the Limit of Image Resolution for Human Expert Classification of Vascular Ultrasound Images in Giant Cell Arteritis and Healthy Subjects: The GCA-US-AI Project
    Location: Poster Hall
    Abstract Poster Presenter: Claus Juergen Bauer, MD – Clinic of Internal Medicine III, Department of Oncology, Hematology, Rheumatology and Clinical Immunology, University Hospital Bonn
    Vasculitis
  • Tuesday, Nov 14th
    11:00 AM – 12:00 PM PT
    14T124: Advancing Non-Invasive Biomarkers in ANCA-Associated Vasculitis and Lupus Nephritis: A Translational State of the Art
    Location: Room 31A-C
    Moderator: Maria Dall'Era, MD (she/her/hers) – UCSF
    Moderator: Sarah Moran, PhD, MBBCH, BAO – Health Service Executive
    Vasculitis
     CME: 1 hours
  • Tuesday, Nov 14th
    11:00 AM – 11:15 AM PT
    Diagnostic Challenges and Monitoring with Current Noninvasive Biomarkers in ANCA-Associated Glomerulonephritis and Lupus Nephritis
    Location: Room 31A-C
    Speaker: Brad Rovin, MD – The Ohio State University
    Vasculitis
  • Tuesday, Nov 14th
    11:15 AM – 11:30 AM PT
    Translating Molecular and Noninvasive Biomarkers for the Diagnosis and Management of ANCA-Associated Glomerulonephritis
    Location: Room 31A-C
    Speaker: Salem Almaani, MD, MS – The Ohio State University Medical Center
    Vasculitis
  • Tuesday, Nov 14th
    11:30 AM – 11:45 AM PT
    Translating Molecular and Noninvasive Biomarkers for the Diagnosis and Management of Lupus Nephritis
    Location: Room 31A-C
    Speaker: Andrea Fava, MD – Johns Hopkins University
    Vasculitis
  • Tuesday, Nov 14th
    11:45 AM – 12:00 PM PT
    Q&A
    Location: Room 31A-C
    Vasculitis
  • Tuesday, Nov 14th
    2:00 PM – 3:30 PM PT
    14T160: Abstracts: Vasculitis – ANCA-Associated II (2491–2496)
    Location: Ballroom 20A
    Abstract Moderator: Mats Junek, MD, MSc – McMaster University
    Abstract Moderator: Despina Michailidou, MD (she/her/hers) – University of Oklahoma and VA Medical Center
    Vasculitis
  • Tuesday, Nov 14th
    2:00 PM – 2:10 PM PT
    2491: Alignment Between the Novel 2022 ACR/EULAR Classification Criteria for ANCA-associated Vasculitis (AAV), Clinical Diagnosis and Organ Manifestations in a European AAV Cohort
    Location: Ballroom 20A
    Presenting Author: Thomas Neumann, MD (he/him/his) – Kantonsspital St. Gallen
    Vasculitis
  • Tuesday, Nov 14th
    2:15 PM – 2:25 PM PT
    2492: The Impact of Neurologic Involvement in ANCA-Associated Vasculitis on Self-Reported Health-Related Quality of Life
    Location: Ballroom 20A
    Presenting Author: Rula A. A. Hajj-Ali, MD – Cleveland Clinic
    Vasculitis
  • Tuesday, Nov 14th
    2:30 PM – 2:40 PM PT
    2493: Renal Prognosis of Dialysis-dependent Patients at Baseline in ANCA-associated Vasculitis
    Location: Ballroom 20A
    Presenting Author: Maxime Vignac, MSc – Université Paris Cité
    Vasculitis
  • Tuesday, Nov 14th
    2:45 PM – 2:55 PM PT
    2494: Complement mRNA Expression in Patients with ANCA-associated Glomerulonephritis
    Location: Ballroom 20A
    Presenting Author: Salem Almaani, MD, MS – The Ohio State University Medical Center
    Vasculitis
  • Tuesday, Nov 14th
    3:00 PM – 3:10 PM PT
    2495: Unbiased Proteomic Approach to Identify Novel Biomarkers of Disease Activity in ANCA- Associated Vasculitis
    Location: Ballroom 20A
    Presenting Author: Zachary Wallace, MD, MSc – Massachusetts General Hospital
    Vasculitis
  • Tuesday, Nov 14th
    3:15 PM – 3:25 PM PT
    2496: HXB-319, a New Generation Mesenchymal Stromal Cell (MSC) Therapy, Alleviates Neutrophilic Inflammation, and End-organ Damage in Pulmonary Renal Syndromes by Inducing FoxP3+ Tregs, and by Promoting TNFα-stimulated gene-6 (TSG-6) over Expression
    Location: Ballroom 20A
    Presenting Author: Hulya Bukulmez, MD (she/her/hers) – MetroHealth Medical Center, Case Western Reserve University
    Vasculitis
  • Tuesday, Nov 14th
    4:00 PM – 5:30 PM PT
    14T179: Abstracts: Vasculitis – Non-ANCA-Associated & Related Disorders II: Clinical (2557–2562)
    Location: Room 6F/6C
    Abstract Moderator: Sharon Chung, MD, MA – University of California, San Francisco
    Abstract Moderator: Audra Horomanski, MD, RhMSUS (she/her/hers) – Stanford University
    Vasculitis
  • Tuesday, Nov 14th
    4:00 PM – 4:10 PM PT
    2557: Clinicopathologic Features of Patients with Giant Cell Arteritis and Thoracic Aorta Repair: A Single Center Experience over Two Decades
    Location: Room 6F/6C
    Presenting Author: Mahmut Kaymakci, MD – Mayo Clinic
    Vasculitis
  • Tuesday, Nov 14th
    4:15 PM – 4:25 PM PT
    2558: Aortic Aneurysms in a Multicenter Cohort of 196 Patients with Aortitis Related to Giant Cell Arteritis Treated with Tocilizumab
    Location: Room 6F/6C
    Presenting Author: Fernando López-Gutierrez, PhD – Rheumatology, Hospital Universitario Marqués de Valdecilla
    Vasculitis
  • Tuesday, Nov 14th
    4:30 PM – 4:40 PM PT
    2559: Clinical Manifestations and Immunomodulatory Treatment in Patients with Relapsing Polychondritis
    Location: Room 6F/6C
    Presenting Author: Shubhasree Banerjee, MD, MBBS – University of Pennsylvania
    Vasculitis
  • Tuesday, Nov 14th
    4:45 PM – 4:55 PM PT
    2560: Risk of Gastrointestinal Perforation Among Patients with Giant Cell Arteritis Who Received Tocilizumab
    Location: Room 6F/6C
    Presenting Author: Desh Nepal, MBBS, FACP – Medical College of Wisconsin, Milwaukee
    Vasculitis
  • Tuesday, Nov 14th
    5:00 PM – 5:10 PM PT
    2561: The Prognostic Value of the “2022 ACR/EULAR Classification Criteria for Giant Cell Arteritis”: Data from the Italian Society of Rheumatology Vasculitis Study Group
    Location: Room 6F/6C
    Presenting Author: Alessandro Tomelleri, MD – IRCCS San Raffaele Hospital, Milan, Italy
    Vasculitis
  • Tuesday, Nov 14th
    5:15 PM – 5:25 PM PT
    2562: Immune Checkpoint Inhibitors-Induced Large Vessel Vasculitis: Data from a Multicenter Study
    Location: Room 6F/6C
    Presenting Author: Adrien Cottu, MD, -None- – Sorbonne Université
    Vasculitis
  • Wednesday, Nov 15th
    10:30 AM – 11:30 AM PT
    15W121: Pediatric Polyarteritis Nodosa: Cutaneous vs. Systemic
    Location: Room 8
    Moderator: Jessica Bloom, MD, MS – University of Colorado
    Moderator: Robert Sundel, MD – Boston Children's Hospital
    Vasculitis
     CME: 1 hours
  • Wednesday, Nov 15th
    10:30 AM – 10:50 AM PT
    Clinical Features and Imaging of Cutaneous and Systemic Polyarteritis Nodosa
    Location: Room 8
    Speaker: Seza Özen, MD, MSc – Hacettepe University Medical Faculty
    Vasculitis
  • Wednesday, Nov 15th
    10:50 AM – 11:00 AM PT
    Q&A
    Location: Room 8
    Vasculitis
  • Wednesday, Nov 15th
    11:00 AM – 11:20 AM PT
    Lessons Learned from Registry Data and Therapeutics for Polyarteritis Nodosa
    Location: Room 8
    Speaker: Tadej Avcin – University Children Hospital, University Medical Center Ljubljana, Department of Allergology, Rheumatology and Clinical Immunology
    Vasculitis
  • Wednesday, Nov 15th
    11:20 AM – 11:30 AM PT
    Q&A
    Location: Room 8
    Vasculitis
  • Wednesday, Nov 15th
    11:00 AM – 12:30 PM PT
    15W126: Abstracts: Vasculitis – Non-ANCA-Associated & Related Disorders III: Innovation (2599–2604)
    Location: Room 33A-C
    Abstract Moderator: Kathleen Maksimowicz-McKinnon, DO, MPH – MUSC
    Abstract Moderator: Sebastian Sattui, MD, MS (he/him/his) – University of Pittsburgh
    Vasculitis
  • Wednesday, Nov 15th
    11:00 AM – 11:10 AM PT
    2599: Study of the Role of interleukin-17 in Giant Cell Arteritis
    Location: Room 33A-C
    Presenting Author: Helene GREIGERT, MD, PhD (she/her/hers) – Dijon University Hospital, France
    Vasculitis
  • Wednesday, Nov 15th
    11:15 AM – 11:25 AM PT
    2600: Clonal Hematopoiesis Is Associated with Giant Cell Arteritis
    Location: Room 33A-C
    Presenting Author: Michelle Robinette, MD, PhD – Brigham and Women's Hospital
    Vasculitis
  • Wednesday, Nov 15th
    11:30 AM – 11:40 AM PT
    2601: Identification of Giant Cell Arteritis Using Plasma Proteome Profiles Integrated with Machine Learning
    Location: Room 33A-C
    Presenting Author: Jaeyun Sung, PhD – Mayo Clinic
    Vasculitis
  • Wednesday, Nov 15th
    11:45 AM – 11:55 AM PT
    2602: Spatially Resolved Cellular Signatures Predict Corticosteroid Treatment Response in Giant Cell Arteritis
    Location: Room 33A-C
    Presenting Author: Cecilia Ansalone, PhD, MSc – University of Glasgow
    Vasculitis
  • Wednesday, Nov 15th
    12:00 PM – 12:10 PM PT
    2603: Impact of IL-6 Receptor Small Nucleotide Polymorphism Asp358Ala on T Cell Activity and Clinical Outcomes in Patients with Giant Cell Arteritis
    Location: Room 33A-C
    Presenting Author: Christopher Redmond, MD, MSc (he/him/his) – West Virginia University
    Vasculitis
  • Wednesday, Nov 15th
    12:15 PM – 12:25 PM PT
    2604: Premature Vascular Smooth Muscle Cells Senescence Driven by Interleukin-6-Mitochondrial STAT3-Mitofusin 2 Signaling in Takayasu’s Arteritis
    Location: Room 33A-C
    Presenting Author: Chenglong Fang, MD – Peking Union Medical College
    Vasculitis